Zivo Bioscience, Inc.
ZIVO
$17.76
$1.7611.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.60M | -2.27M | -8.24M | -1.28M | -1.91M |
| Total Depreciation and Amortization | 98.30K | -- | -- | -- | 91.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 4.90K |
| Total Other Non-Cash Items | 669.10K | 1.09M | 7.58M | 136.70K | 12.30K |
| Change in Net Operating Assets | -71.70K | 90.80K | 37.70K | -557.30K | 1.08M |
| Cash from Operations | -905.70K | -1.09M | -623.70K | -1.70M | -715.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 517.60K | 150.00K |
| Total Debt Repaid | -135.70K | -172.50K | -172.50K | -57.50K | -1.28M |
| Issuance of Common Stock | 2.42M | 1.41M | 660.00K | 1.10M | 640.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.29M | 1.24M | 487.50K | 1.56M | -494.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.38M | 156.90K | -136.20K | -135.70K | -1.21M |